5-HT(2C) Serotonin Receptor Blockade Prevents Tau Protein Hyperphosphorylation and Corrects the Defect in Hippocampal Synaptic Plasticity Caused by a Combination of Environmental Stressors in Mice
Overview
Authors
Affiliations
Exposure to multimodal sensory stressors is an everyday occurrence and sometimes becomes very intense, such as during rave parties or other recreational events. A growing body of evidence suggests that strong environmental stressors might cause neuronal dysfunction on their own in addition to their synergistic action with illicit drugs. Mice were exposed to a combination of physical and sensory stressors that are reminiscent of those encountered in a rave party. However, this is not a model of rave because it lacks the rewarding properties of rave. A 14-h exposure to environmental stressors caused an impairment of hippocampal long-term potentiation (LTP) and spatial memory, and an enhanced phosphorylation of tau protein in the CA1 and CA3 regions. These effects were transient and critically depended on the activation of 5-HT2C serotonin receptors, which are highly expressed in the CA1 region. Acute systemic injection of the selective 5-HT2C antagonist, RS-102,221 (2 mg/kg, i.p., 2 min prior the onset of stress), prevented tau hyperphosphorylation and also corrected the defects in hippocampal LTP and spatial memory. These findings suggest that passive exposure to a combination of physical and sensory stressors causes a reversible hippocampal dysfunction, which might compromise mechanisms of synaptic plasticity and spatial memory for a few days. Drugs that block 5-HT2C receptors might protect the hippocampus against the detrimental effect of environmental stressors.
Yu W, Zhang R, Zhang A, Mei Y Int J Mol Sci. 2025; 26(3).
PMID: 39941002 PMC: 11818420. DOI: 10.3390/ijms26031234.
Study on the Mechanism of Polysaccharide in Reducing Depression-like Behavior in Mice.
Yang C, Chen J, Tang J, Li L, Zhang Y, Li Y Nutrients. 2024; 16(21).
PMID: 39519618 PMC: 11547661. DOI: 10.3390/nu16213785.
Yu M, Shen Z, Zhang S, Zhang Y, Zhao H, Zhang L Heliyon. 2024; 10(13):e33761.
PMID: 39027618 PMC: 11255520. DOI: 10.1016/j.heliyon.2024.e33761.
Psychoplastogenic DYRK1A Inhibitors with Therapeutic Effects Relevant to Alzheimer's Disease.
Warren H, Saeger H, Tombari R, Chytil M, Rasmussen K, Olson D J Med Chem. 2024; 67(9):6922-6937.
PMID: 38648167 PMC: 11152242. DOI: 10.1021/acs.jmedchem.3c01696.
Pierson S, Kolling L, James T, Pushpavathi S, Marcinkiewcz C Pharmacol Res. 2024; 203:107171.
PMID: 38599469 PMC: 11088857. DOI: 10.1016/j.phrs.2024.107171.